Kenvue, the maker of Tylenol, opposes proposed changes to the product's safety label regarding potential links to autism and ...

Kenvue, maker of Tylenol, rejects proposed label changes citing “no proven link” between acetaminophen use in pregnancy and ...

After popular pain med Tylenol came under fire from officials in the Trump administration for an alleged link to autism if ...

Kenvue opposes a Citizen Petition to change Tylenol's pregnancy warning, citing lack of scientific evidence for claims ...

Tylenol maker Kenvue is calling on the Food and Drug Administration (FDA) to back off a proposed safety label change to ...

Tylenol's maker, Kenvue, has strongly opposed a proposed change to the product's safety label, following research suggesting ...

Kenvue, Tylenol manufacturer, has asked US regulators to reject a request for an autism warning label on Tylenol when used ...

The Food and Drug Administration (FDA) defied the advice of its own drug safety experts to warn pregnant women about Tylenol ...

Kenvue, the owners of Tylenol, are pushing back on claims that acetaminophen—the chemical compound in their popular ...

Kenvue stock drops 30% YTD, but Starboard's Jeff Smith remains optimistic, citing leadership changes and brand improvements.

Explore Kenvue Inc. (NYSE:KVUE) trends, dividends, and market activity among consumer stocks in S&P 500 today.